Device and drug manufacturer
S.1244 - FY14 FDA Appropriations bill relating to sequestered user fees. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products.
Issues relating to generic drug labeling.
HR. 1919- Safeguarding America's Pharmaceuticals Act of 2013
S. 957 & S. 959- The Drug Supply Chain of Security Act H.R. 486- relating to the compounding of drug products
House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding
BUD - Budget/Appropriations HCR - Health Issues PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BROWN RUDNICK LLP
601 13th Street, NW, 6th Floor, Washington, DC, 20005, US
HENRY W MENN HENRY W MENN (Min SD & Counsel, Cmte on Vet Affairs (04)) LISA LAYMAN (SPA, Sen Stabenow(05-07)) HENRY W MENN
Min SD & Counsel, Cmte on Vet Affairs (04) SPA, Sen Stabenow(05-07)